VELJUNA owner Contact Information online
from Teva Pharmaceuticals USA, Inc.
VELJUNA
US serial number:85031536
Application filling date:May 06, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Oct. 28, 2013
Publication date:Aug. 03, 2010
Abandoned date:Oct. 28, 2013
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceuticals, namely, oral contraceptives, hormone replacement therapies and hormonal agents for treating the disorders and conditions related to women's health
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Cla
Services:Pharmaceuticals
namely
oral contraceptives
hormone replacement therapies and hormonal agents for treating the disorders and conditions related to women's health
Current owner owner name:Teva Pharmaceuticals USA, Inc.
Current owner owner address:1090 Horsham Road
North Wales,
PENNSYLVANIA
UNITED STATES
19454
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney docket number:TUS-54
Correspondent name address:HERSCHEL PEREL
TEVA PHARMACEUTICALS USA, INC.
425 PRIVET RD
HORSHAM,
PENNSYLVANIA
UNITED STATES
19044-1220
Correspondent phone:215-293-6406
Correspondent email:herschel.perel@tevausa.com
Correspondent email authorized:Yes
Trademark staff tm attorney:SAPPENFIELD, ANN ELIZA
Trademark staff law office assigned VELJUNA:LAW OFFICE 117
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Aug. 03, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
